Robert Mutterperl
Internal Medicine · Tucson, AZNPI 1861438822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Advanced Respiratory, Inc at 24.0% of the total. That places this record below the midpoint for internal medicine clinicians in AZ, where the typical reported total is $142.
Across 7 payments — averaging $20.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Advanced Respiratory, Inc$35
- AbbVie$27
- Arbor Pharmaceuticals, Inc.$20
- Astellas Pharma US Inc$19
- Novo Nordisk$16
- Johnson & Johnson$15
- plus $14 from 1 others
Across 209 payments — averaging $25,276 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$4.7M
- Bavarian Nordic A/s$417K
- AstraZeneca$129K
- Novavax Inc$20K
- Hoffmann-la Roche Limited$14K
What the payments were for
- Food & beverage$147100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Advanced Respiratory, Inc | 1 | $35 |
| AbbVie | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Novo Nordisk | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Novartis | 1 | $14 |
How this compares
$147 in reported general payments places this provider in the 50th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 11 | $894 |
| Levothyroxine Sodium | 24 | $198 |
| Atorvastatin Calcium | 11 | $197 |
| Furosemide | 22 | $105 |
| Metoprolol Tartrate | 14 | $99 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tucson
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Franz RischardTucson$55K
- Nebojsa SkrepnikTucson$48K
- Christine OxleyTucson$44K
- Muhammad HusnainTucson$19K
- Steven WoolTucson$19K
- Surekha BandlamuriTucson$17K
- Augusto PosadasTucson$15K
- Lisa EmmansTucson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.